Compass Pathways raises $80m for treatment-resistant depression

Great news this morning as our resident company Compass Pathways

announced raising $80 million to help bring psilocybin therapy to phase 3 development! Despite the challenges of working through the current pandemic, they've been doing amazing work and we encourage you to follow along. We can't wait to see what comes next!

Check out their website for press and information HERE

Follow them on social media to stay updated! HERE (for Twitter) and HERE (for Linkedin)